Ocular Therapeutix

US · OCUL #2978 by market cap Listed 1970

7.10 -0.14 -1.87%

Live - 5344 symbols - heartbeat 457s ago · 2026-10-08 10:00

Pre-market 7.19 -0.55%

After-hours 7.25 +0.28%

Overnight 7.18 -0.69%

Market cap: 1.56B
P/E (TTM): -5.07
P/B: 3.00
EPS: -1.42
Div yield: 0.00%
52W pos: 8%

Reader sentiment Are you bullish or bearish on OCUL?

Anonymous reader poll. Unscientific, not investment advice.

About Ocular Therapeutix

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Founded: 2006
CEO: Dr. Pravin U. Dugel, M.D.
Employees: 274
Headquarters: Bedford, Massachusetts, United States of America
Fiscal year end: 12-31
Website: ocutx.com

Company profile

Exchange: US
Symbol: OCUL
Market-cap rank: #2978
Listing date: 1970-01-01
Market cap: 1.56B
Float cap: 1.31B
Shares out: 219.62M
Float shares: 184.76M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 10:00:10 · For reference only, not investment advice and not tailored to your situation.